Healthcare & Life Sciences

NURO CORP

Canadanuro.ca
pre-seed
pre-seed
Stage
1
Investors

About

NURO CORP develops a non-invasive brain-computer interface technology called NUOS, enabling communication and interaction through thought and intent without surgery, primarily targeting patients with severe neurological impairments.

Explore NURO CORP's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.